CStone Pharmaceuticals (HKG:2616)

Hong Kong · Delayed Price · Currency is HKD

6.65

+0.22 (3.42%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceuticals	407.21M	463.84M	481.36M	243.72M	1.04B
Pharmaceuticals Growth	-12.21%	-3.64%	97.51%	-76.54%	-
Total	407.21M	463.84M	481.36M	243.72M	1.04B
Total Growth	-12.21%	-3.64%	97.51%	-76.54%	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Mainland China	293.36M	370.23M	-	-	4.72M
Mainland China Growth	-20.76%	-	-	-	-
Outside Mainland China	113.85M	93.61M	-	-	-
Outside Mainland China Growth	21.62%	-	-	-	-
PRC (Excluding Hong Kong and Taiwan)	-	-	476.53M	243.72M	-
PRC (Excluding Hong Kong and Taiwan) Growth	-	-	95.52%	-	-
Others	-	-	4.84M	-	-
United States of America	-	-	-	-	1.03B
Total	407.21M	463.84M	481.36M	243.72M	1.04B
Total Growth	-12.21%	-3.64%	97.51%	-76.54%	-

Source: S&P Global Market Intelligence.